Trial Profile
A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in Amyotrophic Lateral Sclerosis (ALS).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2012
Price :
$35
*
At a glance
- Drugs Arimoclomol (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 01 Aug 2006 Status change
- 21 Oct 2005 New trial record.